Home > Annual Financials > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS Financial Statement Analysis
[NSE : SOTAC]

The Revenues of SOTAC PHARMACEUTICALS have increased by 1.51% YoY .
The Earnings Per Share (EPS) of SOTAC PHARMACEUTICALS has decreased by -28.10 % YoY.
COMMUNITY POLL
for SOTAC PHARMACEUTICALS
Please provide your vote to see the results

SOTAC PHARMACEUTICALS Last 5 Annual Financial Results
[NSE : SOTAC]

ConsolidatedMar2026
Mar2025
Mar2024
Mar2023
Mar2022
Revenues ₹101 Cr₹100 Cr₹104 Cr₹77 Cr₹73 Cr
Expenses ₹83 Cr₹83 Cr₹96 Cr₹70 Cr₹67 Cr
Operating Profit (Excl OI) ₹18 Cr₹16 Cr₹8.32 Cr₹7.32 Cr₹6.17 Cr
Other Income ₹0.35 Cr₹1.15 Cr₹0.49 Cr₹0.35 Cr₹0.22 Cr
Interest ₹4.13 Cr₹2.58 Cr₹1.74 Cr₹2.04 Cr₹0.57 Cr
Depreciation ₹5.41 Cr₹3.84 Cr₹3.10 Cr₹2.28 Cr₹1.13 Cr
Profit Before Tax ₹8.70 Cr₹11 Cr₹3.96 Cr₹3.93 Cr₹4.70 Cr
Profit After Tax ₹6.29 Cr₹9.28 Cr₹3.58 Cr₹2.29 Cr₹2.88 Cr
Consolidated Net Profit ₹5.77 Cr₹8.03 Cr₹4.28 Cr₹2.88 Cr₹2.88 Cr
Earnings Per Share (Rs)₹5.22₹7.26₹3.87₹3.58₹12.52
PAT Margin (%)6.229.303.452.953.94
ROE(%)11.2318.8312.9627.5363.16
ROCE(%)13.2616.4010.2221.5031.31
Total Debt/Equity(x)0.640.820.552.211.12

Key Financials

Market Cap : ₹ 144.3 Cr
Revenue (TTM) : ₹ 95.6 Cr
Net Profit(TTM) : ₹ 3.8 Cr
EPS (TTM) : ₹ 3.4
P/E (TTM) : 38.2

Industry Peers & Returns1W1M1Y
SOTAC PHARMACEUTICALS 16.4% 23.3% -18.7%
SUN PHARMACEUTICAL INDUSTRIES 5.2% 4.3% 8%
DIVIS LABORATORIES 3.6% 7.6% 50.5%
TORRENT PHARMACEUTICALS 3.4% 0.7% 32.6%
CIPLA 2% 6% -6.7%
DR REDDYS LABORATORIES 2.3% 14% 13.6%
MANKIND PHARMA 2.7% 1.8% 5.6%
LUPIN -0.3% -0.9% 1.2%
ZYDUS LIFESCIENCES -3.6% 3.6% 22.8%


SOTAC PHARMACEUTICALS Revenues
[NSE : SOTAC]

Y-o-Y

1.51 %

5 Yr CAGR

8.46 %

Years Revenues % Change
Mar2026 ₹101 Cr
1.51
Mar2025 ₹100 Cr
-3.94
Mar2024 ₹104 Cr
34.00
Mar2023 ₹77 Cr
5.92
Mar2022 ₹73 Cr -


SOTAC PHARMACEUTICALS Operating Profit
[NSE : SOTAC]

Y-o-Y

9.15 %

5 Yr CAGR

30.47 %

Years Operating Profit % Change
Mar2026 ₹18 Cr
9.15
Mar2025 ₹16 Cr
97.05
Mar2024 ₹8.32 Cr
13.67
Mar2023 ₹7.32 Cr
18.52
Mar2022 ₹6.17 Cr -

Operating Margins
Y-o-Y

7.55 %

5 Yr CAGR

20.29 %

Years Operating Margin% % Change
Mar2026 17.67%
7.55
Mar2025 16.43%
105.12
Mar2024 8.01%
-15.15
Mar2023 9.44%
11.85
Mar2022 8.44% -

SOTAC PHARMACEUTICALS Profit After Tax
[NSE : SOTAC]

Y-o-Y

-28.15 %

5 Yr CAGR

18.97 %

Years Profit After Tax % Change
Mar2026 ₹5.77 Cr
-28.15
Mar2025 ₹8.03 Cr
87.50
Mar2024 ₹4.28 Cr
48.65
Mar2023 ₹2.88 Cr
0.03
Mar2022 ₹2.88 Cr -

PAT Margins
Y-o-Y

-33.12 %

5 Yr CAGR

12.09 %

Years PAT Margin(%) % Change
Mar2026 6.22 %
-33.12
Mar2025 9.3 %
169.57
Mar2024 3.45 %
16.95
Mar2023 2.95 %
-25.13
Mar2022 3.94 % -

SOTAC PHARMACEUTICALS Earnings Per Share (EPS)
[NSE : SOTAC]

Y-o-Y

-28.10 %

5 Yr CAGR

-19.64 %

Years EPS % Change
Mar2026 ₹5.22
-28.10
Mar2025 ₹7.26
87.60
Mar2024 ₹3.87
8.10
Mar2023 ₹3.58
-71.41
Mar2022 ₹13 -

SOTAC PHARMACEUTICALS Return on Capital Employed (ROCE)
[NSE : SOTAC]

Y-o-Y

-19.15 %

5 Yr CAGR

-19.33 %

Years ROCE % Change
Mar2026 13.26%
-19.15
Mar2025 16.4%
60.47
Mar2024 10.22%
-52.47
Mar2023 21.5%
-31.33
Mar2022 31.31% -

SOTAC PHARMACEUTICALS Share Price vs Sensex

Current Share Price : ₹130.0
Current MarketCap: ₹ 144.3 Cr
Updated EOD on :Nov 05,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS

16.4%

23.3%

-18.7%

SENSEX

8.8%

10.9%

-4%

SOTAC PHARMACEUTICALS related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about SOTAC PHARMACEUTICALS Financials


How the annual revenues of SOTAC PHARMACEUTICALS have changed ?

The Revenues of SOTAC PHARMACEUTICALS have increased by 1.51% YoY .

How the Earnings per Share (EPS) of SOTAC PHARMACEUTICALS have changed?

The Earnings Per Share (EPS) of SOTAC PHARMACEUTICALS has decreased by -28.10 % YoY .